Home > Riviste > Journal of Neurosurgical Sciences > Fascicoli precedenti > Articles online first > Journal of Neurosurgical Sciences 2020 Sep 28

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

 

Journal of Neurosurgical Sciences 2020 Sep 28

DOI: 10.23736/S0390-5616.20.05048-1

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Efficacy of whole-sellar Gamma Knife Radiosurgery for magnetic resonance imaging-negative Cushing’s disease

Nulifer KILIC DURANKUS 1, Yavuz SAMANCI 2, Meltem YILMAZ 3, Meriç SENGOZ 4, Yasemin BOLUKBASI 5, Selcuk PEKER 6

1 Department of Radiation Oncology, Koç University Hospital, Istanbul, Turkey; 2 Department of Neurosurgery, Koç University Hospital, Istanbul, Turkey; 3 Medical Biotechnology, School of Medicine, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey; 4 Department of Radiation Oncology, School of Medicine, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey; 5 Department of Radiation Oncology, School of Medicine, Koç University, Istanbul, Turkey; 6 Department of Neurosurgery, School of Medicine, Koç University, Istanbul, Turkey


PDF


BACKGROUND: Corticotroph adenoma delineation in Cushing’s disease (CD) patients with previous surgery can be challenging. This study investigated the outcome of wholesellar Gamma Knife Radiosurgery (GKRS) in MRI-negative, but hormone-active CD patients with prior failed treatment attempts.
METHODS: We retrospectively analyzed data of nine CD cases who underwent wholesellar GKRS between April 2008 and April 2020 at a single center. Remission was determined as normal morning serum cortisol, normal 24-hour urinary free cortisol (UFC), or extended postoperative requirement for hydrocortisone replacement.
RESULTS: Median age was 35.0 years, and most of the cases were female (89%). All subjects had undergone previous surgery. The mean pre-GKRS morning serum cortisol and 24-hour UFC was 27.5 mcg/dL and 408.0 mcg, respectively. Target volume varied from 0.6 to 1.8 cc, and the median margin dose was 28 Gy. The median duration of endocrine follow-up was 105 months, and initial endocrine remission was achieved in eight subjects (89%) at a median time of 22 months. The actuarial initial remission was 44% at two years, 67% at four years, and 89% at six years. The mean recurrence-free survival was 128 months. Age and pre-GKRS morning serum cortisol were found to be predictors for initial and durable endocrine remissions. New-onset hypopituitarism was observed in two of five patients (40%). None of the patients developed new neurological deficits and had GKRS-related adverse events during the follow-up.
CONCLUSIONS: Whole-sellar GKRS is a safe and efficient method to manage MRInegative CD and provides similar GKRS outcome rates as in MRI-positive CD.


KEY WORDS: Cortisol; Cushing disease; Gamma Knife Radiosurgery; Remission; Wholesellar

inizio pagina